Bipolar Disorder Therapeutics Market
Bipolar Disorder Therapeutics Market Analysis by Type (Antipsychotics Drugs, Anticonvulsants, Mood Stabilizers, Antidepressant Drugs, Anti-anxiety Drugs), by Region - Global Forecast 2022 to 2026
Analysis of Bipolar Disorder Therapeutics market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Market Outlook of Bipolar Disorder Therapeutics
Demand for bipolar disorder therapeutic drugs is projected to increase at a CAGR of 3.1% from 2022 to 2026.
The global bipolar disorder therapeutics market will account for US$ 5.9 Bn in 2022, and is anticipated to reach a valuation of US$ 6.8 Bn by the end of 2026.
| Report Attributes | Details |
|---|---|
| Bipolar Disorder Therapeutics Market Size (2022) | US$ 5.9 Bn |
| Projected Year Value (2026F) | US$ 6.8 Bn |
| Global Market Growth Rate (2022 to 2026) | 3.1% CAGR |
| United States Market Share (2022) | 44.3% |
| Key Companies Profiled | AstraZeneca; Bristol-Myers Squibb Company; Eli Lilly and Company; Astellas Pharma Inc.; Allergan plc.; Johnson & Johnson; GlaxoSmithKline plc.; AbbVie Inc.; Pfizer Inc.; Novartis International AG.; Gedeon Richter Plc; Lundbeck A/S; Janssen Pharmaceutica N.V.; Otsuka America Pharmaceutical Inc.; Sumitomo Dainippon Pharma Co. Ltd.; Validus Pharmaceuticals LLC |
Consumption of bipolar disorder medications in China is expected to account for a revenue of approximately US$ 514 Mn by the end of 2026.
Increasing prevalence of bipolar disorders and rising awareness regarding mental health are major trends that will driving demand for bipolar disorder therapeutics over the years to come.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Demand Analysis for Bipolar Disorder Therapeutics (2017 to 2021) in Comparison to Market Growth Forecasts (2022 to 2026)
The world has witnessed an increase in focus on mental health over the past few years and this has been majorly driven by increasing stress levels among the population across the globe.
Increasing awareness for bipolar disorders from government initiatives has majorly increased the demand for bipolar disorder medications and is expected to be a prominent trend over the forecast period.
High-stress environments and increasing incidence of substance abuse are major bipolar disorder causes. Rising public awareness about bipolar disorders, rapid advancements in therapeutics development, and increasing caseload of bipolar disorders are other factors that will influence bipolar disorder therapeutics consumption through 2026.
However, the side effects associated with the use of bipolar disorder therapeutic medications are anticipated to hinder market potential throughout the forecast period. From 2022 to 2026, demand for bipolar disorder therapeutics is projected to rise at a steady CAGR of 3.1%.
What Will Majorly Influence Bipolar Disorder Therapeutics Market Size through 2026?
“Increasing Prevalence of Mental Health Disorders across Geographies”
Over the past few years, the incidence of mental health disorders across the world has substantially increased and is expected to rise further over the forecast period.
Early onset of mental illnesses in teenagers and rising public awareness for mental health are major factors that influence bipolar disorder treatment market potential.
Demand for ADHD therapeutics, autism therapeutics, and seasonal affective disorder therapeutics is also expected to rise throughout the forecast period.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Will Related Side Effects Constrain Consumption of Bipolar Disorder Therapeutic Drugs?
“Rising Awareness about Side Effects of Bipolar Disorder Therapeutic Medications Could Hinder Market Growth”
Side effects associated with the use of bipolar disorder therapeutic medications are anticipated to have a restraining effect on global market potential.
Rising awareness among the general population regarding ill effects associated with long-term use of bipolar disorder drugs and increasing patient preference for chemical-free bipolar disorder medication are factors that could slow down bipolar disorder therapeutics demand over the coming years.
What is the Regional Market Outlook for Bipolar Disorder Therapeutics?
“North America Accounts for Major Market Share”
The market for bipolar disorder therapeutics is projected to have a bright outlook in the region of North America owing to rising instances of bipolar disorders. This region is anticipated to hold a dominant market share over the forecast period.
Increasing awareness for bipolar disorders, the presence of advanced an healthcare system, rising incidence of bipolar disorders due to high-stress environments, and poor lifestyle habits are major factors that influence bipolar disorder therapeutics market growth through 2026. Increasing incidence of ADHD (Attention-deficit Hyperactivity Disorder) in this region will drive ADHD therapeutics demand.
Europe bipolar disorder therapeutics market is also anticipated to hold a significant market share owing to rising awareness for mental health and supportive government initiatives to boost the same. Consumption of bipolar disorder therapeutics equipment in Germany is anticipated to evolve at a CAGR of 2.6% throughout the forecast period.
Increasing prevalence of mental disorders in regions of South Asia and East Asia is expected to provide lucrative opportunities for bipolar disorder therapeutics device providers across the forecast period. The bipolar disorder therapeutics market in China is estimated to attain a net value of US$ 514 Mn by 2026.
India and China are projected to emerge as highly rewarding markets in these regions as awareness of bipolar disorders increases through 2026. Rising instances of autism in the aforementioned region are expected to propel the demand for autism therapeutics.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Country-wise Insights
How Lucrative is the U.S. Bipolar Disorder Therapeutics Market?
“High Incidence of Bipolar Disorders to Market Potential in U.S.”
The U.S. bipolar disorder therapeutics market currently accounts for 44.3% of the global bipolar disorder therapeutics industry landscape.
Increasing prevalence of bipolar disorders and rising awareness of mental health are two major trends that will drive bipolar disorder therapeutics market growth through 2026.
Currently, the bipolar disorder therapeutics market in the U.S. holds a net worth of US$ 2.6 Bn.
Category-wise Insights
Will Sales of Mood Stabilizers Increase through 2026?
“Increasing Maniac Episodes & Prevalence of Depression to Drive Demand”
Mania and depression due to mental disorders is a common phenomenon and is often signified by mood swings and sudden mood changes. In order to control these and restore neurochemical balance, mood stabilizers are used and since episodes of depression and mania are on the rise these are anticipated to see high demand.
China, the United States, Canada, and Japan are projected to account for major demand for mood stabilizers through 2026.
How Did the Bipolar Disorder Therapeutics Market Perform in 2020 to 2021?
The bipolar disorder therapeutics market saw a shift in trends as the sudden emergence of COVID-19 put the world in a state of shock. Lockdown restrictions were imposed across multiple nations as an effort to curb the spread of infections and this led to major changes in the world economy and affected various markets in different ways.
With a pandemic situation prevalent on a global scale and most of the world restricted from outdoor activity, a substantial change in mental health was observed under these challenging conditions. Although the demand for bipolar disorder medication was high in 2020, the market did not grow at its full potential owing to an increased focus on coronavirus infection control.
Allotment of major healthcare resources for pandemic led to a decreased focus on other health conditions and hence had a negative impact on the bipolar disorder therapeutics market growth. Consumption of bipolar disorder therapeutic drugs is expected to rise at a slow CAGR in the post-pandemic era owing to rising demand from the increasing caseload of mental health disorders.
Competitive Landscape:
Bipolar disorder treatment providers are investing in the research and development of novel therapeutics to expand their market presence across various regions. Bipolar disorder drug manufacturers are also pushing their offerings to get approvals from regulatory authorities.
- In April 2022, Intra-Cellular Therapies, a leading biopharmaceutical organization known for its therapeutics, announced that it had obtained approval for the new dosage strength of CAPLYTA. This drug has proved its efficiency in the treatment of bipolar disorders and will now be available in strengths of 10.5 mg and 21 mg capsules.
Key Segments Covered in Bipolar Disorder Therapeutics Industry Research
-
By Type:
- Antipsychotics Drugs
- Anticonvulsants
- Mood Stabilizers
- Antidepressant Drugs
- Anti-anxiety Drugs
-
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 4. Market Outlook, by Region
- 5. Market Trend Analysis, 2022 to 2026
- 6. Global Market Analysis and Forecast, by Drug Class, 2022 to 2026
- 6.1. Antipsychotics Drugs
- 6.2. Anticonvulsants
- 6.3. Mood Stabilizers
- 6.4. Antidepressant Drugs
- 6.5. Anti-anxiety Drugs
- 7. Global Market Analysis and Forecast, by Region, 2022 to 2026
- 7.1. North America
- 7.2. Europe
- 7.3. Asia Pacific
- 7.4. Middle East & Africa
- 7.5. Latin America
- 8. North America Market Analysis and Forecast, 2022 to 2026
- 9. Europe Market Analysis and Forecast, 2022 to 2026
- 10. Asia Pacific Market Analysis and Forecast, 2022 to 2026
- 11. Latin America Market Analysis and Forecast, 2022 to 2026
- 12. Middle East & Africa Market Analysis and Forecast, 2022 to 2026
- 13. Competition Landscape
- 13.1. Drug Class Mapping
- 13.2. Bristol-Myers Squibb Company
- 13.3. Eli Lilly and Company
- 13.4. Astellas Pharma Inc.
- 13.5. Allergan plc.
- 13.6. Johnson & Johnson
- 13.7. GlaxoSmithKline plc.
- 13.8. AbbVie Inc.
- 13.9. Pfizer Inc.
- 13.10. Novartis International AG
- 13.11. Gedeon Richter Plc
- 13.12. Lundbeck A/S
- 13.13. Janssen Pharmaceutica N.V.
- 13.14. Otsuka America Pharmaceutical Inc.
- 13.15. Sumitomo Dainippon Pharma Co. Ltd.
- 13.16. Validus Pharmaceuticals LLC
- 14. Assumptions & Acronyms Used
- 15. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 2: Global Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 3: Global Market Value (Mn) Analysis, 2022 to 2026
Table 4: Global Market Value (Mn) Analysis, 2022 to 2026
Table 5: Global Market Value (Mn) Forecast, by Region, 2022 to 2026
Table 6: Global Market Value (Mn) Forecast, by Region, 2022 to 2026
Table 7: North America Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 8: North America Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 9: North America Market Value (Mn) Analysis, 2022 to 2026
Table 10: North America Market Value (Mn) Analysis, 2022 to 2026
Table 11: North America Market Value (Mn) Forecast, by Country, 2022 to 2026
Table 12: North America Market Value (Mn) Forecast, by Country, 2022 to 2026
Table 13: U.S. Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 14: U.S. Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 15: U.S. Market Value (Mn) Analysis, 2022 to 2026
Table 16: U.S. Market Value (Mn) Analysis, 2022 to 2026
Table 17: Canada Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 18: Canada Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 19: Canada Market Value (Mn) Analysis, 2022 to 2026
Table 20: Canada Market Value (Mn) Analysis, 2022 to 2026
Table 21: Europe Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 22: Europe Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 23: Europe Market Value (Mn) Analysis, 2022 to 2026
Table 24: Europe Market Value (Mn) Analysis, 2022 to 2026
Table 25: Europe Market Value (Mn) Forecast, by Country and Sub-region, 2022 to 2026
Table 26: Europe Market Value (Mn) Forecast, by Country and Sub-region, 2022 to 2026
Table 27: Germany Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 28: Germany Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 29: Germany Market Value (Mn) Analysis, 2022 to 2026
Table 30: Germany Market Value (Mn) Analysis, 2022 to 2026
Table 31: U.K. Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 32: U.K. Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 33: U.K. Market Value (Mn) Analysis, 2022 to 2026
Table 34: U.K. Market Value (Mn) Analysis, 2022 to 2026
Table 35: France Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 36: France Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 37: France Market Value (Mn) Analysis, 2022 to 2026
Table 38: France Market Value (Mn) Analysis, 2022 to 2026
Table 39: Italy Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 40: Italy Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 41: Italy Market Value (Mn) Analysis, 2022 to 2026
Table 42: Italy Market Value (Mn) Analysis, 2022 to 2026
Table 43: Spain Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 44: Spain Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 45: Spain Market Value (Mn) Analysis, 2022 to 2026
Table 46: Spain Market Value (Mn) Analysis, 2022 to 2026
Table 47: Russia & CIS Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 48: Russia & CIS Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 49: Russia & CIS Market Value (Mn) Analysis, 2022 to 2026
Table 50: Russia & CIS Market Value (Mn) Analysis, 2022 to 2026
Table 51: Rest of Europe Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 52: Rest of Europe Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 53: Rest of Europe Market Value (Mn) Analysis, 2022 to 2026
Table 54: Rest of Europe Market Value (Mn) Analysis, 2022 to 2026
Table 55: Asia Pacific Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 56: Asia Pacific Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 57: Asia Pacific Market Value (Mn) Analysis, 2022 to 2026
Table 58: Asia Pacific Market Value (Mn) Analysis, 2022 to 2026
Table 59: Asia Pacific Market Value (Mn) Forecast, by Country and Sub-region, 2022 to 2026
Table 60: Asia Pacific Market Value (Mn) Forecast, by Country and Sub-region, 2022 to 2026
Table 61: China Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 62: China Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 63: China Market Value (Mn) Analysis, 2022 to 2026
Table 64: China Market Value (Mn) Analysis, 2022 to 2026
Table 65: Japan Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 66: Japan Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 67: Japan Market Value (Mn) Analysis, 2022 to 2026
Table 68: Japan Market Value (Mn) Analysis, 2022 to 2026
Table 69: India Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 70: India Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 71: India Market Value (Mn) Analysis, 2022 to 2026
Table 72: India Market Value (Mn) Analysis, 2022 to 2026
Table 73: ASEAN Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 74: ASEAN Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 75: ASEAN Market Value (Mn) Analysis, 2022 to 2026
Table 76: ASEAN Market Value (Mn) Analysis, 2022 to 2026
Table 77: Rest of Asia Pacific Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 78: Rest of Asia Pacific Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 79: Rest of Asia Pacific Market Value (Mn) Analysis, 2022 to 2026
Table 80: Rest of Asia Pacific Market Value (Mn) Analysis, 2022 to 2026
Table 81: Latin America Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 82: Latin America Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 83: Latin America Market Value (Mn) Analysis, 2022 to 2026
Table 84: Latin America Market Value (Mn) Analysis, 2022 to 2026
Table 85: Latin America Market Value (Mn) Forecast, by Country and Sub-region, 2022 to 2026
Table 86: Latin America Market Value (Mn) Forecast, by Country and Sub-region, 2022 to 2026
Table 87: Brazil Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 88: Brazil Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 89: Brazil Market Value (Mn) Analysis, 2022 to 2026
Table 90: Brazil Market Value (Mn) Analysis, 2022 to 2026
Table 91: Mexico Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 92: Mexico Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 93: Mexico Market Value (Mn) Analysis, 2022 to 2026
Table 94: Mexico Market Value (Mn) Analysis, 2022 to 2026
Table 95: Rest of Latin America Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 96: Rest of Latin America Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 97: Rest of Latin America Market Value (Mn) Analysis, 2022 to 2026
Table 98: Rest of Latin America Market Value (Mn) Analysis, 2022 to 2026
Table 99: Middle East & Africa Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 100: Middle East & Africa Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 101: Middle East & Africa Market Value (Mn) Analysis, 2022 to 2026
Table 102: Middle East & Africa Market Value (Mn) Analysis, 2022 to 2026
Table 103: Middle East & Africa Market Value (Mn) Forecast, by Country and Sub-region, 2022 to 2026
Table 104: Middle East & Africa Market Value (Mn) Forecast, by Country and Sub-region, 2022 to 2026
Table 105: GCC Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 106: GCC Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 107: GCC Market Value (Mn) Analysis, 2022 to 2026
Table 108: GCC Market Value (Mn) Analysis, 2022 to 2026
Table 109: South Africa Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 110: South Africa Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 111: South Africa Market Value (Mn) Analysis, 2022 to 2026
Table 112: South Africa Market Value (Mn) Analysis, 2022 to 2026
Table 113: Rest of Middle East & Africa Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 114: Rest of Middle East & Africa Market Value (Mn) Forecast, by Drug Class, 2022 to 2026
Table 115: Rest of Middle East & Africa Market Value (Mn) Analysis, 2022 to 2026
Table 116: Rest of Middle East & Africa Market Value (Mn) Analysis, 2022 to 2026
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Price Trend, by Region, 2022 to 2026 (US$/Ton)
Figure 2: Global Market Value Share, by Drug Class, 2022 and 2026
Figure 3: Global Market Attractiveness, by Drug Class
Figure 4: Global Market Value Share, Analysis, 2022 and 2026
Figure 5: Global Market Attractiveness, Analysis
Figure 6: Global Market Value Share, by Region, 2022 and 2026
Figure 7: Global Market Attractiveness, by Region
Figure 8: North America Market Value Share, by Drug Class, 2022 and 2026
Figure 9: North America Market Attractiveness, by Drug Class
Figure 10: North America Market Value Share, Analysis, 2022 and 2026
Figure 11: North America Market Attractiveness, Analysis
Figure 12: North America Market Value Share, by Country, 2022 and 2026
Figure 13: North America Market Attractiveness, by Country
Figure 14: Europe Market Value Share, by Drug Class, 2022 and 2026
Figure 15: Europe Market Attractiveness, by Drug Class
Figure 16: Europe Market Value Share, Analysis, 2022 and 2026
Figure 17: Europe Market Attractiveness, Analysis
Figure 18: Europe Market Value Share, by Country and Sub-region, 2022 and 2026
Figure 19: Europe Market Attractiveness, by Country and Sub-region
Figure 20: Asia Pacific Market Value Share, by Drug Class, 2022 and 2026
Figure 21: Asia Pacific Market Attractiveness, by Drug Class
Figure 22: Asia Pacific Market Value Share, Analysis, 2022 and 2026
Figure 23: Asia Pacific Market Attractiveness, Analysis
Figure 24: Asia Pacific Market Value Share, by Country and Sub-region, 2022 and 2026
Figure 25: Asia Pacific Market Attractiveness, by Country and Sub-region
Figure 26: Latin America Market Value Share, by Drug Class, 2022 and 2026
Figure 27: Latin America Market Attractiveness, by Drug Class
Figure 28: Latin America Market Value Share, Analysis, 2022 and 2026
Figure 29: Latin America Market Attractiveness, Analysis
Figure 30: Latin America Market Value Share, by Country and Sub-region, 2022 and 2026
Figure 31: Latin America Market Attractiveness, by Country and Sub-region
Figure 32: Middle East & Africa Market Value Share, by Drug Class, 2022 and 2026
Figure 33: Middle East & Africa Market Attractiveness, by Drug Class
Figure 34: Middle East & Africa Market Value Share, Analysis, 2022 and 2026
Figure 35: Middle East & Africa Market Attractiveness, Analysis
Figure 36: Middle East & Africa Market Value Share, by Country and Sub-region, 2022 and 2026
Figure 37: Middle East & Africa Market Attractiveness, by Country and Sub-region
Figure 38: Global Market Share Analysis, by Company, 2021
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What valuation does the bipolar disorder therapeutics market enjoy currently?
The global bipolar disorder therapeutics market stands at US$ 5.9 Bn in 2022.
What will be the bipolar disorder therapeutics market revenue total by 2026?
By the end of 2026, the global market for bipolar disorder therapeutics is predicted to reach a valuation of US$ 6.8 Bn.
At what rate is the bipolar disorder therapeutics market projected to rise across the forecast period?
From 2022 to 2026, demand for bipolar disorder therapeutics is anticipated to progress at CAGR 3.1%.
Who are the key suppliers of bipolar disorder therapeutic drugs?
Key bipolar disorder therapeutic drug manufacturers are Astellas Pharma Inc., Allergan plc., Johnson & Johnson, GlaxoSmithKline plc., AbbVie Inc., Pfizer Inc., Novartis International AG., Gedeon Richter Plc, Lundbeck A/S, Janssen Pharmaceutica N.V., and O
What market share is held by the United States?
The U.S. bipolar disorder therapeutics market accounts for 44.3% of the global market share in 2022.
What will the China bipolar disorder therapeutics market be worth by 2026?
By 2026, the China bipolar disorder therapeutics market is anticipated to attain a net worth of US$ 514 Mn.
Bipolar Disorder Therapeutics Market